Description:
Boston Scientific Corp. presents the CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR, an advanced medical device designed to promote optimal heart function in patients with heart disease. This device is mainly used for patients suffering from heart failure and arrhythmias.
The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR is a multi-faceted, implantable device that offers three primary benefits: managing patient's heart rhythm, providing cardiac resynchronization therapy (CRT), and defibrillation therapy. It is a critical tool in the detection and correction of life-threatening ventricular arrhythmias.
1. Heart Rhythm Management: The device continuously monitors the patient's heart rate, detecting and addressing any incidences of abnormal rhythms, effectively preventing cardiac episodes before they occur.
2. Cardiac Resynchronization Therapy (CRT): For patients with heart failure due to dyssynchrony, where the heart’s chambers are not beating together, the device synchronizes the beating of the heart's chambers, subsequently improving the heart's efficiency and the patient's overall quality of life.
3. Defibrillation Therapy: In case of very fast, potentially fatal heart rhythms (arrhythmias), the device delivers a high energy shock to the heart muscle, essentially 'resetting' the heart to its normal rhythm.
The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR by Boston Scientific Corp. is a pivotal tool in maintaining heart health and improving patient outcomes for sufferers of heart disease.